Investor Relations Home

Investor Relations Home

Corporate Profile

Here you will find financial reports and shareholder information about Omeros Corporation, including recent news, current and historical share price, and electronic copies of our SEC filings.

Stock Quote

(Common Stock)
Exchange (US Dollar)
Price
Change (%)   
Volume
Data as of  

Data Provided by Refinitiv. Minimum 15 minutes delayed.

More

Recent Press Releases

Date Title and Summary
Apr 01, 2024 Omeros Corporation Reports Fourth Quarter and Year-End 2023 Financial Results
– Conference Call Today at 4:30 p.m. ET SEATTLE --(BUSINESS WIRE)--Apr. 1, 2024-- Omeros Corporation (Nasdaq: OMER), a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing small-molecule and protein therapeutics for large-market and orphan indications
Mar 27, 2024 Omeros Corporation to Announce Fourth Quarter and Year-End Financial Results on April 1, 2024
SEATTLE --(BUSINESS WIRE)--Mar. 27, 2024-- Omeros Corporation (NASDAQ: OMER), today announced that the company will issue its financial results for the quarter and year ended December 31, 2023 , on Monday, April 1, 2024 , after the market closes. Omeros management will host a conference call and
Feb 20, 2024 Omeros Corporation Announces Upcoming Presentation Detailing Narsoplimab Compassionate Use in Nine Patients with Hematopoietic Stem Cell Transplant-associated Thrombotic Microangiopathy
SEATTLE --(BUSINESS WIRE)--Feb. 20, 2024-- Omeros Corporation (Nasdaq: OMER) today announced the upcoming presentation of a report detailing narsoplimab treatment in nine adult patients with hematopoietic stem cell transplant-associated thrombotic microangiopathy (TA-TMA).
Feb 01, 2024 Omeros Corporation Announces Additional Royalty Monetization with DRI Healthcare Trust
– Expands DRI royalty deal on U.S. net sales of OMIDRIA – – Expanded deal brings Omeros $115 million upfront payment and opportunity for additional $55 million in sales-based milestones – SEATTLE --(BUSINESS WIRE)--Feb. 1, 2024-- Omeros Corporation (Nasdaq: OMER) today announced the sale to DRI
More

Upcoming Events

There are currently no events to display.
More
Featured Reports

Receive E-mail Alerts

Sign up to receive e-mail alerts whenever Omeros Corporation posts new information to the site. Just enter your e-mail address and click Submit.
We use cookies to ensure our website works properly and to collect statistics about users in order for us to improve the website. If you continue to browse this site, you will accept our use of cookies. For more information, please read our Privacy Policy.

© 2024 Omeros All rights reserved